Skip to main content
SpringerLink
Log in

Pentoxifyllin

  • Chapter
Neuro-Psychopharmaka

  • 43 Accesses

Zusammenfassung

In vitro-Studien haben belegt, daß nach Zugabe von Pentoxifyllin zu Konservenblut gesunder Personen die Erythrozyten-Filtrierbarkeit signifikant erhöht wird unter den Bedingungen der Alterung (Ambrus et al. 1984, Grigoleit und Jacobi 1977, Seiffge und Kiesewetter 1981), unter hyperosmolaren Bedingungen (Ehrly 1975, Leonfiardt und Grigoleit 1977), nach Zitratgabe (Schubotz und Mühlfellner 1977), nach Zusatz von Milchsäure (Seiffge und Kiesewetter 1981) und Calciumchlorid (Seiffge und Kiesewetter 1981).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adisasmito NA, Wiradinata BW (1979) The clinical effect of pentoxifyline (Trental) in the treatment of geriatric patients. Singapore Med J [Suppl 1] 20: 20–25

    Google Scholar 

  • Ambrus JL, Ambrus CM, Taheri SA, Gastpar H, Reddington MM (1984) Red cell flexibility and platelet aggregation in patients wirh chronic obstructive vascular disease (COAD) and study of therapeutic approaches. Angiology 35: 418–426

    PubMed  CAS  Google Scholar 

  • Angelkort B (1979) Thrombozytenfunktion, plasmatische Blutgerinnung und Fibrinolyse bei chronisch arterieller Verschlußkrankheit. Med Welt 30: 1239–1248

    PubMed  CAS  Google Scholar 

  • Angelkort B (1981) Coagulation phenomena and blood fluidity in peripheral occlusive arterial disease. Study with pentoxifylline. In: Manrique, Müller (eds) Disorders of blood flow; new therapeutic aspects. Excerpta Medica, Amsterdam, pp 68–79

    Google Scholar 

  • Angelkort B, Bauerdick H (1982) Zum Verhalten des Herzrhythmus bei digitalisierten Patienten mit zusätzlicher Pentoxifyllin-Medikation. Therapiewoche 32: 5369–5371

    Google Scholar 

  • Angelkort B, Doppelfeld E (1983) The treatment of chronic arterial occlusion: a clinical study with a new formulation of pentoxifylline (Trental 400). Pharmatherapeutica 3 [Suppl] 18–29

    Google Scholar 

  • Baskerville VW (1980) Clinical trial with pentoxifylline in geriatric patients with cerebral circulatory insufficiency. Revista Brasà de Clinicà e Terapeutica 9: 41–50

    Google Scholar 

  • Baumann JC (1978) A clinical pharmacological comparison of the two compounds, pentoxifylline and xanthinol nicotinate. Pharmatherapeutica [Suppl 1]: 58–65

    Google Scholar 

  • Beermann B, Ings R, MåNsby J, Chamberlain J, McDonald A (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37: 25–28

    PubMed  CAS  Google Scholar 

  • Beyreder J (1983) Use of pentoxifylline in the treatment of acute cerebrovascular insufficiency. Eur Neurol 22 [Suppl V]: 116–123

    PubMed  Google Scholar 

  • Black RS, Barclay LL, Nolan KA, Thaler HT, Hardiman ST, Blass JP (1992) Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc 40: 237–244

    PubMed  CAS  Google Scholar 

  • Biamino G (1986) Influence of a single IV dose of pentoxifylline on central haemodynamics in patients with ischemic heart disease. IRCS Med Sci 14: 82–83

    Google Scholar 

  • Bluhm RE, Molnar J, Cohen MM (1985) The effect of pentoxifylline on the energy metabolism of ischemic gerbil brain. Clin Neuropharmacol 8: 180–285

    Google Scholar 

  • Blume JK, Rühlmann U, De La Haye R, Reftig H, Oltmer G (1990) Vasculär bedingte Hirnleistungsstämngen im Alter. Langzeittherapie mit Pentoxifyllin und psychologischem Ferntraining. Fortschr Med 108: 638–642

    PubMed  CAS  Google Scholar 

  • Bowton DL, Stump DA, Prough DS, Toole JF, Lefkowitz DS, Coker L (1989) Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease. Stroke 20: 1662–1666

    PubMed  CAS  Google Scholar 

  • Brancato R, Menchini U, Michelone C (1983) Evaluation of the action of pentoxifylline on the conjunctival microcirculation in diabetics. Pharmatherapeutica 3 [Suppl 1]: 42–45

    Google Scholar 

  • Bryce TA, Burrow JL, Jolley KW (1985) Determination of 1-(3’-carboxypropyl)-3,7-dimenthylxanthine and 1-(4’-carboxybutyl)3,7dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography. J Chromatogr 344: 397–402

    PubMed  CAS  Google Scholar 

  • Buchanan N, Moodley GP (1977) The effect of pentoxifylline on human erythrocyte adenosine triphosphate. IRCS Med Sci 5: 43

    CAS  Google Scholar 

  • Christ O, Gleixner K, Kellner RM, Müller R, Rupp W (1972) Pharmakokinetische Untersuchungen nach oraler Verabreichung von 3,7-dimethyl-1-(5-oxo-hexyl)-xanthin-14C (BL 191***14C) an Ratten, Hunden und Menschen. Arzneimittelforschung 22: 1933–1937

    PubMed  CAS  Google Scholar 

  • Cohen MM, Harrison W, Gray R, Becker R (1979) The effect of pentoxifylline on cerebral ischemia and amino acid incorporation into gerbil brain. Proceedings of the Annual Meeting of the American Neurology Association, St. Louis

    Google Scholar 

  • Di Perri T, Carandente O, Vitroria A, Guerrini M, Messa GL (1984) Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease. Angiology 35: 427–435

    PubMed  Google Scholar 

  • Dominguez D, De Cayaffa CL, Gomensoro J, Aparicio NJ (1977) Modification of psychometric, practical and intellectual parameters in patients with diffuse cerebrovascular insufficiency during prolonged treatment with pentoxifylline: a double-blind, placebo controlled trial. Pharmatherapeutica 1(8) 498–506

    Google Scholar 

  • Ehrly AM (1975) Beeinflussung der Verformbarkeit der Erythrocyten durch Pentoxifyllin. Med Welt 26: 2300–2301

    PubMed  CAS  Google Scholar 

  • Ehrly AM (1975) The effect of pentoxifylline on the flow properties of hyperosmolar blood. IRCS Med Sci 3: 465

    CAS  Google Scholar 

  • Ehrly AM (1982) Effects of orally administred pentoxifylline on muscular oxygen pressure in patients with intermittent claudication. IRCS Med Sci 10: 401–402

    Google Scholar 

  • Eisenberg S (1966) Blood viscosity and fibrinogen concentration following cerebral infarction. Circulation 24 [Suppl 2]: 10–14

    Google Scholar 

  • Faraci FM, Lopez JAG, Breese K, Armstrong ML, Heistad DD (1991) Effect of atherosclerosis on cerebral vascular responses to activation of leukocytes and platelets in monkeys. Stroke 22: 790–796

    PubMed  CAS  Google Scholar 

  • Feine-Haake G (1983) Assessment of the therapeutic efficacy of pentoxifylline (Trental 400): a double-blind trial in geriatric patients with vascular disorders. Pharmatherapeutica 3 [Suppl 1]: 46–51

    Google Scholar 

  • Flamm P, Lehrach F, Weiser HG (1978) Durchblutungsstörungen des Netzhaut-Aderhaut-Bereichs und ihre Behandlungsmöglichkeiten mit Pentoxifyllin. Therapiewoche 28: 9911–9918

    Google Scholar 

  • Fukuda I, Yoshida T, Yoritsune H, Kiso T, Konishi S et al. (1978) Studies on the hemorheological factor in ischemic heart disease and cerebrovascular disorders. Bull Osaka Med School 24: 83–91

    CAS  Google Scholar 

  • Gabaschwili VM, Kobaladze SG, Schakaraschwili RR, Virsaladze MD, Petriaschwili SP et al. (1979) The cerebral haemodynamics and therapeutic efficacy of pentoxifylline in patients with cerebral ischaemia. Curr Med Res Opin 6 [Suppl 4]: 25–29

    Google Scholar 

  • Gallasch G (1985) Ergebnisse und Indikationsstellung medikamentöser Therapie bei arteriellen und venösen Gefäßverschlüssen der Retina durch Erythrosklerose. Fortschr Ophthalmol 82: 102–104

    PubMed  CAS  Google Scholar 

  • Gallenkamper W, Rucker W, Schrör K (1984) Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia. Br J Pharmacol 81: 575–581

    PubMed  CAS  Google Scholar 

  • Gallus AS, Morley AA, Gleadow F, Wenzel A, Dupont P (1985) Intermittent claudication: a double-blind crossover trial of pentoxifylline. Austr N Z J Med 15: 402–409

    CAS  Google Scholar 

  • Ganser V, Boksay I (1974) Effect of pentoxifylline on cerebral edema in cats. Neurology 24: 487–493

    PubMed  CAS  Google Scholar 

  • Ghose K (1987) Oxpentifylline in dementia: a controlled study. Arch Gerontol Geriatr 6: 19–26

    PubMed  CAS  Google Scholar 

  • Grigoleit HG, Jacobi G (1977) Microrheological effects of the vasoactive compound 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (Pentoxifylline, BL 191). Vasa 6: 274–278

    PubMed  CAS  Google Scholar 

  • Grigoleit HG, Porsche E, Stefanovich V, Jacobi G, Lahham A (1976) The effect of pentoxifylline on red cell flexibility in healthy subjects after administration of Trental 400. Pharmatherapeutica 1: 241–247

    Google Scholar 

  • Habu K, Hara Y, Mikami Y, Honda M (1978) Studies on the erythrocyte osmotic fragility of patients suffering from vibration disease testet with the coil planet centrifuge. J Jpn Accident Med Assoc 26: 703–715

    Google Scholar 

  • Hartmann A (1983) Effect of pentoxifylline on regional cerebral blood flow in patients with cerebral vascular disorders. Eur Neurol 22 [Suppl 1]: 108–115

    PubMed  Google Scholar 

  • Hartmann JF, Becker RA, Cohen MM (1977) Effects of pentoxifylline on cerebral ultrastructure of normal and ischemic gerbils. Neurology 27: 77–84

    PubMed  CAS  Google Scholar 

  • Hartmann A, Alberti E, Lange D (1979) Effect of pentoxifylline on regional CBF and CBV in dementia. Acta Neurol Scand 60 [Suppl 72]: 624–625

    Google Scholar 

  • Harwart D (1979) The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline (Trental 400). Curr Med Res Opin 6: 73–84

    PubMed  CAS  Google Scholar 

  • Hayashi S, Ozawa H (1974) Sudies on 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthine (BL191). I. Cyclic 3,’5’-nucleotide phosphodiesterase (PDE) and the inhibitory effect of BL191 on PDE in rat brain and heart. Chem Pharmaceut Bull 22: 587–593

    CAS  Google Scholar 

  • Heidrich H, Ou M (1974) Vasodilatantien und Blutviskosität. Herz-Kreislauf 6: 542–546

    Google Scholar 

  • Heidrich H, Paeprer M, Barekow D, Schartl M (1976) The effect of pentoxifylline on central and peripheral hemodynamics — an experimental clinical study. Z Kardiol 65: 385–391

    PubMed  CAS  Google Scholar 

  • Herskovits E (1989) Randomized double-blind study of pentoxifylline (Trental) versus acetylsalicylic acid (ASA) in multi-infarct dementia. Acta Neurol Scand [Suppl 127]: 31–35

    Google Scholar 

  • Herskovits E, Famulari A, Tamaroff L, Smud R, Vazquez A et al. (1981) Randomised trial of pentoxifylline versus acetylsalicylic acid + dipyridamole in preventing transient ischemic attacks. Lancet i: 966–967

    Google Scholar 

  • Herskovits E, Famulari A, Tamaroff L, Gonzales AH, Vazquez A et al. (1985) Preventive treatment of cerebral transient ischemia: comparative randomised trial of pentoxifylline vs conventional aggregants. Eur Neurol 24: 73–81

    PubMed  CAS  Google Scholar 

  • Hinze HJ (1972) The pharmacokinetics of 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man. Arzneimittelforschung 22: 1492–1495

    PubMed  CAS  Google Scholar 

  • Hinze HJ, Bedessem G, Söder A (1972) Structure of the excretion products of 3,7-Dimethyl-1-(5oxo-hexyl)-xanthine (BL 191) in man. Arzneimittelforschung 22: 1144–1151

    PubMed  CAS  Google Scholar 

  • Hinze HJ, Grigoleit HG, Rethy B (1976) Bioavailability and pharmacokinetics of pentoxifylline from Trental 400 in man. Pharmatherapeutica 1: 160–171

    CAS  Google Scholar 

  • Hsu CY, Norris JW, Hogan E L (1988) Pentoxifylline in acute nonhemorrhagic stroke: a randomized, placebo-controlled double-blind trial. Stroke 19: 716–721

    PubMed  CAS  Google Scholar 

  • Ingerslev J, Mouriken G, Stenbjerg S (1986) Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study. Pharmatherapeutica 4: 595–600

    PubMed  CAS  Google Scholar 

  • Itoh T, Satoh T (1979) Influence of pentoxifylline (Trental) on platelet aggregation and serum lipids in patients with obstructive cerebrovascular disorders. Pharmatherapeutica 2: 159–164

    Google Scholar 

  • James DR, Holland BM, Hughes MR, Jones JG, Wardrop CAJ (1984) Oxpentifylline: effects on red cell deformability and oxygen availability from blood in intermittent claudication. Clin Hemorheol 4: 525–531

    Google Scholar 

  • Janaki S (1980) Pentoxifylline in strokes: a clinical study. J Int Med Res 8: 56–62

    PubMed  CAS  Google Scholar 

  • Jarrett PEM, Moreland M, Browse NL (1977) The effect of oxpentifylline on fibrinolytic activity and plasma fibrinogen levels. Curr Med Res Opin 4: 492–495

    CAS  Google Scholar 

  • Jovanovic UJ (1972) Polygraphische Registriemngen nach parenteraler Applikation von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthine (BL191). Arzneimittelforschung 22: 994–999

    PubMed  CAS  Google Scholar 

  • Katsunuma H, Imamura T, Ishigaki Y (1982) The clinical efficacy of Trental against various types of cerebrovascular disease. J New Remedies Clin 31: 1845–1851

    Google Scholar 

  • Kiesewetter H, Schneider R, Jurig F et al. (1986) Therapie zerebraler Mikroangiopathien. Untersuchungen mit niedermolekularer Hydroxyäthylstärke mit und ohne Pentoxifyllin. Therapiewoche 36: 50–55

    Google Scholar 

  • Kobaladze SG, Gibradze TA (1979) Einwirkung von Trental (Pentoxifyllin) auf das experimentell ischämische Myokard. Proceedings of the Van Swieten Congress, Vienna, October 1979, pp 269–270

    Google Scholar 

  • Kobaladze SG, Schonia GS (1979) Pentoxifylline and some physicochemical aspects of haemorheology in patients with ischaemic heart disease, Curr Med Res Opin 6 [Suppl 4]: 5–11

    Google Scholar 

  • Kobaladze SG, Tschikvadze IV (1979) The use of pentoxifylline in the treatment of ischaemic heart disease. Curr med Res Opin 6 [Suppl 4]: 12–15

    Google Scholar 

  • Körber N, Schneider R, Brockmann M, Kiesewetter H, Reim M (1986) Retinale Durchblutung bei lakunären Infarkten unter Therapie mit Pentoxifyllin. Med Welt 37: 1376–1378

    Google Scholar 

  • Komarek Von J, Hüsselrath A, Just M (1977) Effect of pentoxifylline on cerebral blood flow and metabolism in dogs. Arzneimittelforschung 27: 1939–1942

    PubMed  CAS  Google Scholar 

  • Kostka-Trabkowa E, Demblinska-Kiec A, Grodzinska L, Bieron K, Gryglewski RJ (1985) Beneficial results of pentoxifylline (Trental) therapy in arteriosclerosis obliterans: possible mechanism of action. Curr Med Res Opin 9: 407–416

    PubMed  CAS  Google Scholar 

  • Kramer JJ, Swislocki MI (1983) Effects of pentoxifylline on membrane protein phosphorylation in rat erythrocytes. Vascular Med 1: 159–173

    Google Scholar 

  • Lagrue G, Gumpelson A, Kamalodine T, Berge D (1977) Effects de la pentoxifylline sur les modifications microcirculatoires au cours des arteriopathies (hypertension artérielle, diabète). Semain Hôpital Paris Therapeutique 53: 441–444

    CAS  Google Scholar 

  • Lecomte MC, Boivin P (1981) Effects of methylxanthine derivatives on red cell phosphorylation. Scan J Clin Lab Invest 41 [Suppl 156]: 291–295

    CAS  Google Scholar 

  • Lee MM, Hong KP, Oh BH, Choi YS, Seo J et al. (1980) A clinical study on pentoxifylline (Trental) in the treatment of cerebrovascular disease. Korean Circ J 12: 51–55

    Google Scholar 

  • Leonhardt H, Grigoleit HG (1977) Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Naunyn-Schmiedebergs Arch Pharmacol 299: 197–200

    PubMed  CAS  Google Scholar 

  • Lukas MA (1984) Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs conventional antiaggregants: a six-month randomized follow-up study. Angiology 35: 443–450

    Google Scholar 

  • Manrique R (1983) Blood coagulation, rheology and coronary reocclusion after local thrombolysis in myocardial infarction. Abstract Volume XII World Congress, International Union of Angiology, Rochester, Minnesota, USA, Sept 11–16

    Google Scholar 

  • Martin P, Vives P (1979) Déformabilité des globules rouges et accidents vasculaires cérébraux: intérêt de la pentoxifylline. Gazette Méd France 86: 2585–2587

    Google Scholar 

  • Martin P, Vives P (1980) The effect of pentoxifylline on red cell deformability in cerebrovascular accidents. Curr Med Res Opin 6: 518–522

    PubMed  CAS  Google Scholar 

  • Matrai A, Ernst E (1985) Pentoxifylline improves white cell rheology in claudicants. Clin Hemorrheol 5: 483–491

    Google Scholar 

  • Mattern H, Niemeier H (1979) Enhanced blood circulation as a result of improved microcirculation. Ärztliche Praxis 31: 2638–2640

    Google Scholar 

  • Matzky R, Darius H, Schrör K (1982) The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue. Arzneimittelforschung/ Drug Res 32: 1315–1318

    CAS  Google Scholar 

  • Mayer H, Grunau G, Spoors KH (1975) Behandlung arterieller und arterio-venöser Durchblutungsstörungen mit Trental. Therapiewoche 25: 4941–4949

    Google Scholar 

  • Metoki H, Kudo R, Shimanaka Y, Matsui T, Kanazawa T (1983) A study on blood viscosity in cerebrovascular disease. Hirosaki Med J 35: 1–10

    Google Scholar 

  • Meyer JS, Rogers RL, Mc Clintic K, Mortel KF, Lotfi J (1989) Randomized clinical trial of daily aspirin therapy in multi-infarct dementia — a pilot study. JAGS 37: 549–555

    CAS  Google Scholar 

  • Micic DV, Stefanovich V, Mrsulja BB (1981) The effect of pentoxifylline on cytotoxic form of ischemic brain edema in mongolian gerbil. IRCS Med Sci 9: 709

    CAS  Google Scholar 

  • Moirarn DV, Cortiana M, Taglioretti D (1983) Applicazione della filtrazione eritrocitaria nello studio della vasculopatia diabetica: efficacia terapeutica della pentossifillina. Clin Ter 106: 19–25

    Google Scholar 

  • Müller RV (1981) Hemorheology and peripheral vascular diseases — a new therapeutical approach. J Med 12: 209–235

    PubMed  Google Scholar 

  • Müller R, Lehrach F (1981) Haemorheology and cerebrovascular disease: multi-functional approach with pentoxifylline. Curr Med Res Opin 7: 253–263

    PubMed  Google Scholar 

  • Müller R, Muskic P (1987) Haemorheology in surgery — a review. Angiology 38: 581–591

    PubMed  Google Scholar 

  • Muggeo M, Calabro A, Businaro V, Patussi L, Volpe A, Signorini GP, Crepaldi G (1983) Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: the effects of pentoxifylline in the treatment of acute cerebral vascular disease. Pharmatherapeutica 3 [Suppl 1]: 74–90

    Google Scholar 

  • Nenci GG, Gresele P, Agnelli G, Ballatori E (1981) Effect of pentoxifylline on platelet aggregation. Pharmatherapeutica 2: 532–538

    PubMed  CAS  Google Scholar 

  • Nordhus O, Ekeström S, Liljeqvist L (1986) Effects of pentoxifylline on central haemodynamics in patients with congestive heart failure. Scand J Thorac Cardiovasc Surg 20: 217–220

    PubMed  CAS  Google Scholar 

  • De Oliveira RSP, De Miranda AAV (1977) Estudo eletroencefalografico e psicologico com BL191 em pacientes geronto-psiquiatrico. Rev Bras Med 34: 85–93

    Google Scholar 

  • Ott E, Lechner H, Aranibar A (1974) High blood viscosity syndrome in cerebral infarction. Stroke 5: 330–334

    PubMed  CAS  Google Scholar 

  • Ott E, Fazekas F, Lechner H (1983) Haemorheological effects of pentoxifylline in disturbed blood flow behaviour in patients with cerebrovascular disease. Eur Neurol 22 [Suppl 1]: 105–107

    PubMed  Google Scholar 

  • Ott E, Fazekas F, Valetitsch H et al. (1986) The rationale of rheological pharmacological therapy. Clin Hemorheol 6: 35–40

    Google Scholar 

  • Parnetti L, Ciuffetti G, Mercuri M et al. (1986) The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline (Trental 400) in elderly patients with initial mental deterioration. Pharmatherapeutica 4: 617–627

    PubMed  CAS  Google Scholar 

  • Passero S, Nardini M, Battistini M (1981) Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease. J Int Med Res 9: 211–214

    PubMed  CAS  Google Scholar 

  • Perego MA, Sergio G, Artale F, Giunti P, Danese C (1986) Haemorheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease. Curr Med Res Opin 10: 135–138

    PubMed  CAS  Google Scholar 

  • Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A (1984) Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication. Angiology 35: 366–372

    PubMed  CAS  Google Scholar 

  • Pettegrew J, Kopp S, Glonek T (1983) P-31 nuclear magnetic resonance study of pentoxifylline effect on experimental cerebral ischemia. Neurology 33 [Suppl 2]: 152

    Google Scholar 

  • Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GGN (1985) Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. Angiology 36: 628–636

    PubMed  CAS  Google Scholar 

  • Pohanka E, Sinzinger H (1986) Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, Plasma 6-oxo-PGF1 α and Thromboxane B2 in healthy volunteers. Prostagland Leukot Med 22: 191–200

    CAS  Google Scholar 

  • Popendiker U, Boksay I, Bollmann V (1971) Zur Pharmakologie des neuen peripheren Gefäßdilatators 3,7-dimethyl-1-(5-oxo-hexyl)-xanthin. Arzneimittelforschung 21: 1160–1171

    PubMed  CAS  Google Scholar 

  • Porsche E, Stefanovich V (1978) The effect of pentoxifylline on A I Pase activity of human erythrocyte membranes. IRCS Med Sci 6: 285

    CAS  Google Scholar 

  • Pupita F, Rotatori P, Frausini G (1983) Clinical pharmacology of vasoactive drugs: studies on pentoxifylline. Pharmatherapeutica 3 [Suppl 1]: 102–110

    Google Scholar 

  • Raithel D, Kasprzak P (1985) Prevention of reocclusion after synthetic prosthetic bypassoperations in femoropopliteal area: comparative randomized study of pentoxifylline versus acetylsalicylic acid. Angiology 36: 678

    Google Scholar 

  • Roekaerts F, Deleers L (1984) Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration. Angiology 35: 396–406

    PubMed  CAS  Google Scholar 

  • Sakai T, Okada J, Hara M, Ogashiwa M, Takeuchi K (1985) Red cell defomability in patients with cerebral vasospasm. Int J Clin Pharmacol Ther Toxicol 23: 79–82

    PubMed  CAS  Google Scholar 

  • Satewachin II, Iljin VN, Scihestakov VA, Alexandrova NP, Rodionov SV et al. (1978) The use of pentoxifylline in a combined regimen for the prevention of re-thrombosis in major blood vessels. Pharmatherapeutica 2: 109–117

    Google Scholar 

  • Schneider R, Brockmann M, Kiesewetter H (1986) Behandlung lakunärer Infarkte mit Pentoxifyllin. Med Welt 37: 1340–1343

    Google Scholar 

  • Schmalzer EA, Chien S (1984) Filterability of subpopulations of leukocytes: effect of pentoxifylline. Blood 64: 542–546

    PubMed  CAS  Google Scholar 

  • Schreiber P, Schröppel M, Heidrich H (1983) Effects of naftidrofuryl, pentoxifylline and bencyclane on the renal blood flow and renal excretion of conscious dogs. Herz 15: 195–201

    CAS  Google Scholar 

  • Schubotz R, Mühlfellner O (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4: 609–617

    PubMed  CAS  Google Scholar 

  • Schultheiss R, Leuwer R, Leniger-Follert E, Wassmann H, Wüllenweber R (1986) Tissue pO2 of human brain cortex-method, basic results and effects of pentoxifylline. Angiology 37: 398–401

    Google Scholar 

  • Seiffge D (1982) Effect of pentoxifylline on red cell aggregation (RCA). IRCS Med Sci 8: 727

    Google Scholar 

  • Seiffge D, Kiesewetter H (1981) Filterability investigations with red blood cell (RBC) suspensions: effects of different blood components and pentoxifylline on RBC flow rate. Ric Clin Lab 11 [Suppl 1]: 117–123

    PubMed  Google Scholar 

  • Seiffge D, Kremer E (1984) Antithrombotic effects of pentoxifylline on laser-induced thrombi in rat mesenteric arteries. IRCS Med Sci 12: 91–92

    CAS  Google Scholar 

  • Sen S, Chakravarty A (1977) Clinical experience with pentoxifylline in occlusive cerebrovascular disorders. Angiology 28: 340–345

    PubMed  CAS  Google Scholar 

  • Smith RV, Waller ES, Doluisio JT, Banzer MT, Puri SK et al. (1986) Pharmacokinetics of orally administered pentoxifylline in humans. J Pharmaceut Sci 75: 47–52

    CAS  Google Scholar 

  • Smud R, Sermukslis B, Kartin D (1976) Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1: 229–233

    Google Scholar 

  • Solerte SB, Fioravanti M, Bozzetti A (1986) Pentoxifylline, albumin excretion rate and proteinuria in type I and II diabetic patients with microproteinuria. Results of a short term randomized study. Acta Diabetol Lat 23: 171–176

    PubMed  CAS  Google Scholar 

  • Stauch M, Richter P, Roth J, Herrmann T, Schmutz C et al. (1986) Kardiale Wirkung von Pentoxifyllin bei Patienten mit koronarer Herzerkrankung in Ruhe und während Belastung. Herz/Kreislauf 18: 489–495

    Google Scholar 

  • Steen PA, Milde JH, Michenfelder JD (1982) Pentoxifylline in regional cerebral ischemia in cats. Acta Anaesthesiol Scand 26: 39–43

    PubMed  CAS  Google Scholar 

  • Stefanovich V, John JP (1978) Influence of pentoxifylline on brain metabolism of normal and anoxic rats. Arzneimittelforschung 28: 2097–2099

    PubMed  CAS  Google Scholar 

  • Stefanovich V, Jarvis P, Grigoleit HG (1977) The effect of pentoxifylline on the 3’5’ cyclic AMP-system in bovine platelets. Int J Biochem 8: 359–364

    CAS  Google Scholar 

  • Strano A, Davi G, Avellone G, Novo S, Pinto A (1984) Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35: 439–446

    Google Scholar 

  • Takamatsu S, Sato K, Takamatsu M, Sakuta S, Mizuno S (1979) Changes in haematological and blood chemical parameters after treatment of aged arteriosclerotic patients with pentoxifylline. Pharmatherapeutica 2: 165–172

    Google Scholar 

  • Tonak J, Knecht H, Groitl H (1983) Treatment of circulatory disturbances with pentoxifylline: a double-blind study with Trental. Pharmatherapeutica 3 [Suppl 1]: 126–135

    Google Scholar 

  • Ueda N, Muteki T, Tajiri M, Tayama F, Tsutsumi Y, Watanabe H et al. (1979) Clinical evaluation of the effect of pentoxifylline on circulatory behaviour of the brain. Kurume Med J 26: 331–334

    PubMed  CAS  Google Scholar 

  • Vasthare US, Heinel LA, Rosenwasser RH, Tuma RF (1990) Leucocyte involvement in cerebral ischemia and reperfusion injury. Surg Neurol 33: 261–265

    PubMed  CAS  Google Scholar 

  • Völker D (1976) Haemorheological investigations in patients with vascular disease undergoing treatment with pentoxifylline. Pharmatherapeutica 1: 154–159

    Google Scholar 

  • Völker D (1983) Treatment of arteriopathies with pentoxifylline (Trental 400). Results of a double-blind study. Pharmatherapeutica 3 [Suppl 1]: 136–142

    Google Scholar 

  • Watanabe H, Furukawa Y, Chiba S (1982) Cardiovascular effects of aminophylline and pentoxifylline on intact dogs and isolated dog atria. Jpn Heart J 23: 235–243

    PubMed  CAS  Google Scholar 

  • Weichert W, Breddin HK (1985) Antithrombotic effects of acetylsalicylic acid (AS) and pentoxifylline in laser-induces thrombosis in rat mesenteric vessels. Vasa 14: 280–284

    PubMed  CAS  Google Scholar 

  • Wenig HG, Koppenhagen K (1981) Effects of pentoxifylline on cerebral and hepatic blood flow: scintigraphic measurements in patients with cerebrovascular insufficiency and liver disease. In: Manrique, Müller (eds) Disorders of blood flow: new therapeutic aspects. Excerpta Medica, Amsterdam, pp 95–106

    Google Scholar 

  • Wills RF, Waller ES, Puri SK, Ho I, Yakatan GJ (1981) Influence of food on the bioavailability of Trental (pentoxifylline) in man. Drug Development and Industrial Pharmacy 7: 385–396

    CAS  Google Scholar 

  • Zinzadse KI, Gulischwili LN, Tavchelidse TD, Vorobjov OJ (1978) The effect of pentoxifylline on the flow properties of blood in experimental atherosclerosis in rabbits. Pharmatherapeutica 2: 118–122

    Google Scholar 

  • Zoppo Del GJ, Schmidt-Schönbein GW, Mori E, Copeland BR, Chang CHM (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276–1283

    PubMed  Google Scholar 

Download references

Authors
  1. H. Herrschaft
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Universitätsklinik, Würzburg, Bundesrepublik Deutschland

    Peter Riederer

  2. Psychiatrische Universitätsklinik, Bonn, Bundesrepublik Deutschland

    Gerd Laux

  3. Psychiatrische Universitätsklinik, Basel, Schweiz

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Wien

About this chapter

Cite this chapter

Herrschaft, H. (1992). Pentoxifyllin. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3330-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3330-9_16

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3331-6

  • Online ISBN: 978-3-7091-3330-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation